Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Receptor imaging: competitive or complementary to antibody imaging?

S J Goldsmith1

  • 1Division of Nuclear Medicine, New York Hospital-Connell Medical Center, New York 10021, USA.

Seminars in Nuclear Medicine
|April 1, 1997
PubMed
Summary

Radiolabeled ligands and antibodies offer improved tumor scintigraphy. Receptor-ligand tracers show better contrast, while antibodies may evolve into smaller, more effective agents for tumor imaging.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cases of Litholapaxy Performed on Children.

The Indian medical gazette·2017
Same author

Imaging Multidrug Resistance in Hematological Malignancies.

Hematology (Amsterdam, Netherlands)·2016
Same author

An overview of the diagnostic and therapeutic use of monoclonal antibodies in medicine.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...·2011
Same author

Oedipus or Orestes? Homosexual men, their mothers, and other women revisited.

Journal of the American Psychoanalytic Association·2002
Same author

Positron emission tomography in lymphoma: comparison with computed tomography and Gallium-67 single photon emission computed tomography.

Clinical lymphoma·2001
Same author

Procedure guideline for somatostatin receptor scintigraphy with (111)In-pentetreotide.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2001

Area of Science:

  • Nuclear Medicine
  • Oncology
  • Molecular Imaging

Background:

  • Radiolabeled ligands and antibodies provide novel scintigraphic tumor identification methods.
  • These agents offer higher affinity and specificity compared to traditional imaging agents like Gallium-67 and Technetium-99m MIBI.
  • Differences in molecular weight impact plasma survival, tumor permeation, and background activity, affecting image contrast.

Purpose of the Study:

  • To compare the efficacy of radiolabeled ligands and antibodies for tumor imaging.
  • To discuss the current status and future directions for these advanced tumor-binding tracers.
  • To explore the potential for a hybrid technology combining the strengths of both approaches.

Main Methods:

  • Utilizing radiolabeled ligands targeting specific cell surface receptors.

Related Experiment Videos

  • Employing radiolabeled antibodies targeting specific cell surface epitopes.
  • Analyzing molecular weight, affinity, specificity, plasma survival, and background activity of tracers.

    • Main Results:

    • Both radiolabeled ligands and antibodies have shown encouraging clinical results for tumor identification.
    • Receptor-ligand tracers currently offer superior contrast compared to antibodies or antibody fragments.
    • Further development is needed for both agent types to optimize tumor imaging.

    Conclusions:

    • Receptor-ligand imaging requires advancements in understanding receptor biology and radiochemical techniques.
    • Future radiolabeled antibodies may involve fragments or polymerized units for improved tumor penetration and clearance.
    • A hybrid technology, 'radiolabeled molecular recognition units,' may emerge, combining high affinity and specificity for tumor imaging.